Nervous Times for NDA Sponsors: The New Reality of FDA Drug Reviews

FDA is adopting a broad range of procedural changes in response to suggestions from outside critics to address drug safety issues. The most significant change, however, may be just a new state of mind.

More from Archive

More from Pink Sheet